| 2022-12-23 |
The dietary flavonol kaempferol inhibits epstein-barr virus reactivation in nasopharyngeal carcinoma cells |
Molecules. 2022 Dec 23;27(23):Article number 8158. |
 |
| 2022-12-22 |
Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-kappaB and TGF-Beta2 signaling |
Journal of Biomedical Science. 2022 Dec 22;29:Article number 109. |
|
| 2022-12-15 |
An integrated microfluidic system for cholangiocarcinoma diagnosis from bile by using specific affinity probes |
Sensors and Actuators B-Chemical. 2022 Dec 15;373:Article number 132724. |
|
| 2022-12-15 |
Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway |
Life Sciences. 2022 Dec 15;311(Part A):Article number 121135. |
|
| 2022-12-01 |
Dihydromyricetin inhibited migration and invasion by reducing S100A4 expression through ERK1/2/beta-catenin pathway in human cervical cancer cell lines |
International Journal of Molecular Sciences. 2022 Dec 1;23(23):Article number 15106. |
|
| 2022-12-01 |
Methylation of TET2 promoter is associated with global hypomethylation and hypohydroxymethylation in peripheral blood mononuclear cells of systemic lupus erythematosus patients |
Diagnostics. 2022 Dec 1;12(12):Article number 3006. |
|
| 2022-12 |
Recalibrating risk prediction models by synthesizing data sources: Adapting the lung cancer PLCO model for Taiwan |
Cancer Epidemiology, Biomarkers and Prevention. 2022 Dec 5;31(12):2208-2218. |
|
| 2022-12 |
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high risk, early breast cancer |
Annals of Oncology. 2022 Dec;33(12):1250-1268. |
|
| 2022-12 |
Mitochondrial AAA protease gene associated with immune infiltration is a prognostic biomarker in human ovarian cancer |
Pathology Research and Practice. 2022 Dec;240:Article number 154215. |
|
| 2022-12 |
Distinct immunogenetic profiles of chronic lymphocytic leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study |
HemaSphere. 2022 Dec;6(12):Article number e803. |
|
| 2022-12 |
PARP1 recruits DNA translocases to restrain DNA replication and facilitate DNA repair |
PLoS Genetics. 2022 Dec;18(12):Article number e1010545. |
|
| 2022-11-24 |
High vs. low radiotherapy dose in locally advanced esophageal squamous cell carcinoma patients treated with neoadjuvant concurrent chemoradiotherapy: An endemic area population-based study |
Discover Oncology. 2022 Nov 24;13:Article number 130. |
|
| 2022-11-15 |
The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma |
American Journal of Cancer Research. 2022 Nov 15;12(11):5062-5073. |
|
| 2022-11-14 |
Optimizing margin status for improving prognosis in patients with oral cavity squamous cell carcinoma: A retrospective study from the two highest-volume Taiwanese hospitals |
Frontiers in Oncology. 2022 Nov 14;12:Article number 1019555. |
|
| 2022-11-06 |
PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation |
Journal of Biomedical Science. 2022 Nov 06;29:Article number 92. |
|
| 2022-11-01 |
Revisiting the cerebral hemodynamics of awake, freely moving rats with repeated ketamine self-administration using a miniature photoacoustic imaging system |
Neurophotonics. 2022 Nov 01;9(4):Article number 045003. |
|
| 2022-11 |
CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer |
British Journal of Cancer. 2022 Nov;127(9):1615-1628. |
|
| 2022-11 |
High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT |
Pathology, Research and Practice. 2022 Nov;239:Article number 154158. |
|
| 2022-11 |
Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC) |
Annals of Oncology. 2022 Nov;33(Suppl. 9):S1462-S1463. |
|
| 2022-11 |
BEAR study: A single-arm, phase II trial of BI-754091 and afatinib for refractory esophageal squamous cell carcinoma |
Annals of Oncology. 2022 Nov;33(Suppl. 9):S1472-S1473. |
|
| 2022-11 |
PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan |
Journal of the American Society of Nephrology. 2022 Nov;33(11S):150. |
|
| 2022-11 |
Comparison of single-cell transcriptomic profiles of early and late peritoneal dialysis |
Journal of the American Society of Nephrology. 2022 Nov;33(11S):449. |
|
| 2022-10-31 |
PD-L1 expression in high-risk early-stage colorectal cancer-its clinical and biological significance in immune microenvironment |
International Journal of Molecular Sciences. 2022 Oct 31;23(21):Article number 13277. |
|
| 2022-10-30 |
Multi-omics analysis reveals clinical value and possible mechanisms of ATAD1 down-regulation in human prostate adenocarcinoma |
Life. 2022 Oct 30;12(11):Article number 1742. |
|
| 2022-10-27 |
A framework for detecting noncoding rare-variant associations of large-scale whole-genome sequencing studies |
Nature Methods. 2022 Oct 27;19:1599-1611. |
|
| 2022-10-23 |
Real-world comparative effectiveness of nivolumab versus pembrolizumab in patients with unresectable hepatocellular carcinoma |
Pharmaceutics. 2022 Oct 23;14(11):Article number 2263. |
|
| 2022-10-22 |
Vickers hardness value test via multi-task learning convolutional neural networks and image augmentation |
Applied Sciences. 2022 Oct 22;12(21):Article number 10820. |
|
| 2022-10-20 |
Reprogramming of sentinel lymph node microenvironment during tumor metastasis |
Journal of Biomedical Science. 2022 Oct 20;29:Article number 84. |
|
| 2022-10-11 |
Upregulated ubiquitin D is a favorable prognostic indicator for rectal cancer patients undergoing preoperative concurrent chemoradiotherapy |
OncoTargets and Therapy. 2022 Oct 11;15:1171-1181. |
|
| 2022-10-10 |
Prognostic abilities of pre- and post-treatment inflammatory markers in oral squamous cell carcinoma: Stepwise modelling |
Medicina. 2022 Oct 10;58(10):Article number 1426. |
|
| 2022-10 |
Chronic mechanical irritation enhances the effect of tobacco and alcohol on the risk of oral squamous cell carcinoma: A case-control study in Argentina |
Clinical Oral Investigations. 2022 Oct;26(10):6317-6326. |
|
| 2022-10 |
The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma |
Hepatology International. 2022 Oct;16(5):1137-1149. |
|
| 2022-10 |
Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study |
Clinical Cancer Research. 2022 Oct 3;28(19):4248-4257. |
|
| 2022-10 |
Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma - with emphasis on locoregional therapy for oligoprogression |
Hepatology. 2022 Oct;76(Suppl.1):S1411-S1412. |
|
| 2022-10 |
An integrated microfluidic device for automated detection of cancer cells from bile for cholangiocarcinoma prognosis |
MicroTAS 2022 - 26th International Conference on Miniaturized Systems for Chemistry and Life Sciences. 2022 Oct:229-230. |
|
| 2022-09-26 |
Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend? |
Journal of Biomedical Science. 2022 Sep 26;29:Article number 74. |
|
| 2022-09-21 |
Clustering of chromatin remodeling enzymes predicts prognosis and clinical benefit of therapeutic strategy in pancreatic cancer |
International Journal of Medical Sciences. 2022 Sep 21;19(10):1615-1627. |
|
| 2022-09-15 |
Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin |
American Journal of Cancer Research. 2022 Sep 15;12(9):4267-4278. |
|
| 2022-09-13 |
UMOD mutations in chronic kidney disease in Taiwan |
Biomedicines. 2022 Sep 13;10(9):Article number 2265. |
|
| 2022-09 |
Beta-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral cancer patients |
Oral Diseases. 2022 Sep;28(6):1484-149. |
|
| 2022-09 |
Neuropsychiatric symptoms and mortality among patients with mild cognitive impairment and dementia due to Alzheimer's disease |
Journal of the Formosan Medical Association. 2022 Sep;121(9):1705-1713. |
|
| 2022-09 |
Multi-kinase inhibitors for the treatment of asymptomatic radioactive Iodine-refractory differentiated thyroid cancer: Global non-interventional study (RIFTOS MKI) |
Thyroid. 2022 Sep;32(9):1059-1068. |
|
| 2022-09 |
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study |
European Journal of Cancer. 2022 Sep;173:123-132. |
|
| 2022-09 |
High MT2A expression predicts worse prognosis in patients with urothelial carcinoma |
Oncology. 2022 Sep;100(9):485-497. |
|
| 2022-09 |
Systemic treatment of advanced unresectable hepatocellular carcinoma after first-line therapy: Expert recommendations from Hong Kong, Singapore, and Taiwan |
Liver Cancer. 2022 Sep;11(5):426-439. |
|
| 2022-09 |
Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC) |
Annals of Oncology. 2022 Sep;33(7):S565-S566. |
|
| 2022-08-28 |
Injectability, processability, drug loading, and antibacterial activity of gentamicin-impregnated mesoporous bioactive glass composite calcium phosphate bone cement in vitro |
Biomimetics. 2022 Aug 28;7(3):Article number 121. |
|
| 2022-08-07 |
Selenium yeast and fish oil combination diminishes cancer stem cell traits and reverses cisplatin resistance in A549 sphere cells |
Nutrients. 2022 Aug 7;14(15):Article number 3232. |
|
| 2022-08 |
STAT3 Inactivation and Induction of Apoptosis Associate With Fluoxetine-inhibited Epithelial-mesenchymal Transition and Growth of Triple-negative Breast Cancer In Vivo |
Anticancer Research. 2022 Aug;42(8):3807-3814. |
|
| 2022-08 |
IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis |
Cell and Bioscience. 2022 Aug;12:Article number 124. |
|
